178 related articles for article (PubMed ID: 33217540)
21. Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients.
Golocheikine A; Nath DS; Basha HI; Saini D; Phelan D; Aloush A; Trulock EP; Hachem RR; Patterson GA; Ahearn JM; Mohanakumar T
J Heart Lung Transplant; 2010 Apr; 29(4):410-6. PubMed ID: 20022265
[TBL] [Abstract][Full Text] [Related]
22. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
[TBL] [Abstract][Full Text] [Related]
23. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
25. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
26. Antibody-Mediated Rejection After Liver Transplant.
Lee M
Gastroenterol Clin North Am; 2017 Jun; 46(2):297-309. PubMed ID: 28506366
[TBL] [Abstract][Full Text] [Related]
27. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
[TBL] [Abstract][Full Text] [Related]
28. C3d and C4d deposition early after lung transplantation.
Westall GP; Snell GI; McLean C; Kotsimbos T; Williams T; Magro C
J Heart Lung Transplant; 2008 Jul; 27(7):722-8. PubMed ID: 18582800
[TBL] [Abstract][Full Text] [Related]
29. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
Husain AN; Mirza KM; Fedson SE
J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
[TBL] [Abstract][Full Text] [Related]
30. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
31. C4d deposition in peritubular capillary and alloantibody in the allografted kidney suffering severe acute rejection.
Abe M; Sawada T; Horita S; Toma H; Yamaguchi Y; Teraoka S
Clin Transplant; 2003; 17 Suppl 10():14-9. PubMed ID: 12823251
[TBL] [Abstract][Full Text] [Related]
32. C4d deposition in cardiac allografts correlates with alloantibody.
Smith RN; Brousaides N; Grazette L; Saidman S; Semigran M; Disalvo T; Madsen J; Dec GW; Perez-Atayde AR; Collins AB
J Heart Lung Transplant; 2005 Sep; 24(9):1202-10. PubMed ID: 16143234
[TBL] [Abstract][Full Text] [Related]
33. Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction.
Martin L; Charon-Barra C; Bocrie O; Guignier F; D'Athis P; Dautin G; de la Vega MF; Justrabo E; Rifle G; Mousson C
Transpl Immunol; 2010 Feb; 22(3-4):110-4. PubMed ID: 19900552
[TBL] [Abstract][Full Text] [Related]
34. C4d binding correlated with strong HLA antibodies involved in graft failures.
Mizutani K; Gotoh M
Transplant Proc; 2010 Dec; 42(10):4021-5. PubMed ID: 21168616
[TBL] [Abstract][Full Text] [Related]
35. Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.
Ajona D; Razquin C; Pastor MD; Pajares MJ; Garcia J; Cardenal F; Fleischhacker M; Lozano MD; Zulueta JJ; Schmidt B; Nadal E; Paz-Ares L; Montuenga LM; Pio R
PLoS One; 2015; 10(3):e0119878. PubMed ID: 25799154
[TBL] [Abstract][Full Text] [Related]
36. In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts.
Bartel G; Wahrmann M; Exner M; Regele H; Huttary N; Schillinger M; Körmöczi GF; Hörl WH; Böhmig GA
Am J Transplant; 2008 Jan; 8(1):41-9. PubMed ID: 17924995
[TBL] [Abstract][Full Text] [Related]
37. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
38. Increased lung allograft failure in patients with HLA-specific antibody.
Girnita AL; McCurry KR; Zeevi A
Clin Transpl; 2007; ():231-9. PubMed ID: 18637473
[TBL] [Abstract][Full Text] [Related]
39. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.
Torrealba JR; Samaniego M; Pascual J; Becker Y; Pirsch J; Sollinger H; Odorico J
Transplantation; 2008 Dec; 86(12):1849-56. PubMed ID: 19104433
[TBL] [Abstract][Full Text] [Related]
40. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy.
Yang L; Lu YP; Luo GH; Song J; Tu ZD; Li YP
Transplant Proc; 2008 Oct; 40(8):2786-9. PubMed ID: 18929862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
